Regarding the article entitled “Hypersensitivity to antibiotics in patients with cystic fibrosis”
نویسندگان
چکیده
منابع مشابه
Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
Background Hypersensitivity reactions to parenteral administered antibiotics (HRPA) are a substantial problem in managing pulmonary disease in Cystic Fibrosis (CF), especially in advanced CF. This group of patients requires a life long antibiotic treatment with extremely high cumulative doses compared to other patients. In our daily routine we observed a growing number of hypersensitivities. Th...
متن کاملCystic fibrosis from genotype to phenotype: review article
Cystic fibrosis (CF) is the most common autosomal recessive genetic disease, which is caused by defection in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. CFTR gene codes chloride channels to modulate the homeostasis of epithelial environments. Defective CFTR affects various organs such as the lungs, pancreas, intestine, liver and skin; however, lung impairment is the mai...
متن کاملAntibiotics in Cystic Fibrosis.
IN cystic fibrosis the main problem is the susceptibility of the children to respiratory infection. The clinical course of the untreated case is one of repeated respiratory infections followed by persistent pulmonary sepsis, and later death. Severe attacks may occur in the first weeks or months of life, or less commonly, years may pass with no, or minimal symptoms referable to the chest. Upper ...
متن کاملOutcome of Cystic Fibrosis in Patients with Bronchiectasis
Introduction: Bronchiectasis is a common problem in children especially under 5 years. Early diagnosis of disease and its causes could be useful in early treatment and preventing probable complications. This study aimed at evaluating the cystic fibrosis (CF) in patients with bronchiectasis. Methods: In a cross-sectional study, 374 children with bronchiectasis were studied. The diagnosis was ma...
متن کاملUse of aerosolized antibiotics in patients with cystic fibrosis.
T here has been a renewed interest in the use of aerosolized antibiotics in cystic fibrosis (CF) patients during the past decade. Potential benefits of delivering antibiotics by aerosol include the following: direct delivery of antibiotics to the endobronchial site of infection; decreased toxicity as systemic absorption is limited; reduced cost; and less disruption to patients’ lives, especiall...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cystic Fibrosis
سال: 2014
ISSN: 1569-1993
DOI: 10.1016/j.jcf.2013.12.008